Health, Medicine and Natural Healing 10

282,028 topics in this forum

1. Vertex Telaprevir Starting FDA Approval This Summer

   By Guest guest, April 22, 2010
   • 0 replies
   • 48 views
   • 
   • Guest
   • April 22, 2010

2. Vertex Telaprevir Starting FDA Approval This Summer

   By Guest guest, April 22, 2010
   • 0 replies
   • 28 views
   • 
   • Guest
   • April 22, 2010

3. Vertex to Ask for Telaprevir OK Later in 2010

   By Guest guest, January 11, 2010
   • 0 replies
   • 40 views
   • 
   • Guest
   • January 11, 2010

4. Vertex to Ask for Telaprevir OK Later in 2010

   By Guest guest, January 12, 2010
   • 3 replies
   • 34 views
   • 
   • Guest
   • January 12, 2010

5. Vertex to Ask for Telaprevir OK Later in 2010

   By Guest guest, January 11, 2010
   • 1 reply
   • 24 views
   • 
   • Guest
   • January 12, 2010

6. Vertex Will Study All-Oral Regimen of HCV Protease Inhibitor Telaprevir plus Polymerase Inhibitor VX-222

   By Guest guest, March 5, 2010
   • 0 replies
   • 20 views
   • 
   • Guest
   • March 5, 2010

7. Vertex Will Study All-Oral Regimen of HCV Protease Inhibitor Telaprevir plus Polymerase Inhibitor VX-222

   By Guest guest, March 5, 2010
   • 0 replies
   • 39 views
   • 
   • Guest
   • March 5, 2010

8. Vertex, J&J Hepatitis C Drug Works After Others Fail

   By Guest guest, September 9, 2010
   • 0 replies
   • 25 views
   • 
   • Guest
   • September 9, 2010

9. Vertex, Merck Drugs Help More with Faster Cure for Hepatitis C in Studies

   By Guest guest, October 30, 2010
   • 0 replies
   • 21 views
   • 
   • Guest
   • October 30, 2010

10. Vertex, Merck Drugs Help More with Faster Cure for Hepatitis C in Studies

    By Guest guest, October 30, 2010
    • 0 replies
    • 28 views
    • 
    • Guest
    • October 30, 2010

11. Vertex, Worth $7.5B, Eagerly Awaits Final Proof that Hepatitis C Drug Works

    By Guest guest, May 17, 2010
    • 0 replies
    • 38 views
    • 
    • Guest
    • May 17, 2010

12. Vertex;VX-222 and Telaprevir, Vertex disclosed rebound in viral load in phase IIb study

    By Guest guest, October 26, 2010
    • 0 replies
    • 47 views
    • 
    • Guest
    • October 26, 2010

13. Vertex;VX-222 and Telaprevir, Vertex disclosed rebound in viral load in phase IIb study

    By Guest guest, October 26, 2010
    • 0 replies
    • 60 views
    • 
    • Guest
    • October 26, 2010

14. Vertex’s telaprevir and Merck’s boceprevir/ Hope Against Hepatitis C

    By Guest guest, July 22, 2010
    • 0 replies
    • 24 views
    • 
    • Guest
    • July 22, 2010

15. Vertex’s telaprevir and Merck’s boceprevir/ Hope Against Hepatitis C

    By Guest guest, July 22, 2010
    • 0 replies
    • 21 views
    • 
    • Guest
    • July 22, 2010

16. Vertex’s telaprevir, Schering Plough’s boceprevir, and Human Genome Sciences’ Zalbin

    By Guest guest, February 5, 2010
    • 0 replies
    • 19 views
    • 
    • Guest
    • February 5, 2010

17. Vertex’s telaprevir, Schering Plough’s boceprevir, and Human Genome Sciences’ Zalbin

    By Guest guest, February 6, 2010
    • 0 replies
    • 25 views
    • 
    • Guest
    • February 6, 2010

18. vertical integration

    By Guest guest, January 29, 2010
    • 0 replies
    • 37 views
    • 
    • Guest
    • January 29, 2010

19. vertical lines on nails???

    By Guest guest, October 1, 2010
    • 0 replies
    • 24 views
    • 
    • Guest
    • October 1, 2010

20. Vertigo

    By Guest guest, April 14, 2010
    • 0 replies
    • 20 views
    • 
    • Guest
    • April 14, 2010

21. vertigo

    By Guest guest, April 16, 2010
    • 0 replies
    • 21 views
    • 
    • Guest
    • April 16, 2010

22. Vertigo

    By Guest guest, March 5, 2010
    • 0 replies
    • 39 views
    • 
    • Guest
    • March 5, 2010

23. Vertigo

    By Guest guest, December 10, 2010
    • 0 replies
    • 20 views
    • 
    • Guest
    • December 10, 2010

24. Vertigo

    By Guest guest, March 5, 2010
    • 0 replies
    • 34 views
    • 
    • Guest
    • March 5, 2010

25. Vertigo

    By Guest guest, March 4, 2010
    • 0 replies
    • 25 views
    • 
    • Guest
    • March 4, 2010